Medinet Co Ltd (2370.T) Key Developments | Reuters.com
Edition:
United States

Medinet Co Ltd (2370.T)

2370.T on Tokyo Stock Exchange

140JPY
10:17pm EDT
Change (% chg)

¥1 (+0.72%)
Prev Close
¥139
Open
¥140
Day's High
¥142
Day's Low
¥139
Volume
238,300
Avg. Vol
2,168,322
52-wk High
¥270
52-wk Low
¥109

Latest Key Developments (Source: Significant Developments)

MEDINET expects extraordinary profit for Q3 of FY 2016
Wednesday, 27 Apr 2016 02:00am EDT 

MEDINET Co Ltd:Expected extraordinary profit of 198 mln yen for Q3 of FY ending Sep. 2016 for selling of investment securities.  Full Article

MEDINET signs business outsourcing contract
Sunday, 28 Feb 2016 10:00pm EST 

MEDINET Co Ltd:Says signed education business outsourcing contract with National Center for Child Health and Development, to provide education assistance in accordance with operational management of cell processing facility.  Full Article

MEDINET announces business alliance with Whiz Partners
Tuesday, 29 Sep 2015 02:45am EDT 

MEDINET Co Ltd:Forms a business alliance with Whiz Partners Inc. on Sep. 29.Says the two entities to be engaged in cell processing business and cell medical care product business.  Full Article

MEDINET signs agreement with The University of Tokyo
Thursday, 24 Sep 2015 11:00pm EDT 

MEDINET Co Ltd:To start joint research with The University of Tokyo, for research in immuno-cell therapy (CTL) using iPS cells.  Full Article

MEDINET announces business alliance with Biotherapy Institute of Japan
Wednesday, 5 Aug 2015 10:30pm EDT 

MEDINET Co Ltd:Forms a business alliance with Biotherapy Institute of Japan. on Aug. 6.Says the two entities will mainly cooperate on realization of a stable supply structure in regenerative and cell medicine area, as well as promotion and expansion of regenerative and cell medicine business in the next year.  Full Article

MEDINET to dissolve joint venture
Wednesday, 5 Aug 2015 02:00am EDT 

MEDINET Co Ltd:Says to dissolve a Tokyo-based joint venture that established with PURPOSE CO., LTD. and a Hokkaido-based company on Sep. 26, 2013.The company holds 33.3 pct stake in the joint venture.Planned liquidation completion date Nov. 25.  Full Article

MEDINET signs licensing contract with Becton, Dickinson and Company
Monday, 22 Jun 2015 02:00am EDT 

MEDINET Co Ltd:Signs a licensing contract with Becton, Dickinson and Company (BD).To develop product using monoclonal antibody through the license agreement, and make the new monoclonal antibody commercialized.  Full Article

MEDINET expects extraordinary loss for Q3 of FY 2015
Monday, 18 May 2015 03:00am EDT 

MEDINET Co Ltd:Says it expects an extraordinary loss of 30 million yen for Q3 of FY ending Sep. 2015.Says the loss is recorded for loss on disposal of fixed assets.  Full Article

MEDINET expects extraordinary loss for Q2 of FY 2015
Friday, 27 Mar 2015 05:45am EDT 

MEDINET Co Ltd:Expects extraordinary loss of 50 mln yen for Q2 of FY ending Sep. 2015, due to settlement payment.  Full Article

MEDINET announces patent in Japan
Wednesday, 18 Feb 2015 01:30am EST 

MEDINET Co Ltd:Announces patent in Japan for new monoclonal antibody and its uses that regarding BTN3 molecule.  Full Article